The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Al Sorkhy, Mohammad ^a   Ferraiuolo, Rosa Maria ^b   Jalili, Espanta ^b   Malysa, Agnes ^b   Fratiloiu, Andreea R ^c   Sloane, Bonnie F ^d   Porter, Lisa A ^b  

^a AL ZAYTOONAH UNIVERSITY OF JORDAN   (Jordan)

^b UNIVERSITY OF WINDSOR   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; RINGO PROTEIN; SPY1 PROTEIN; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL ACTIVATION; CELL CULTURE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN;

ANIMALS; BREAST NEOPLASMS; CDC2 PROTEIN KINASE; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FIBROBLASTS; FORKHEAD TRANSCRIPTION FACTORS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MICROARRAY ANALYSIS; NIH 3T3 CELLS; TUMOR CELLS, CULTURED;

EID: 84856118979     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-45     Document Type: Article

References (23)

1. Karaiskou A, Perez LH, Ferby I, Ozon R, Jessus C, Nebreda AR. Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins. J Biol Chem 2001, 276:36028-36034. 10.1074/jbc.M104722200, 11461916.
2. Porter LA, Dellinger RW, Tynan JA, Barnes EA, Kong M, Lenormand JL, Donoghue DJ. Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2. J Cell Bio 2002, 157:357-366.
3. Porter LA, Donoghue DJ. Cyclin B1 and CDK1: nuclear localization and upstream regulators. Prog Cell Cycle Res 2003, 5:335-347.
4. McAndrew CW, Gastwirt RF, Meyer AN, Porter LA, Donoghue DJ. Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27. Cell Cycle 2007, 6:1937-1945. 10.4161/cc.6.15.4520, 17671428.
5. Porter LA, Kong-Beltran M, Donoghue DJ. Spy1 interacts with p27Kip1 to allow G1/S progression. Mol Biol Cell 2003, 14:3664-3674. 10.1091/mbc.E02-12-0820, 196558, 12972555.
6. Zucchi I, Mento E, Kuznetsov VA, Scotti M, Valsecchi V, Simionati B, Vicinanza E, Valle G, Pilotti S, Reinbold R, et al. Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis. Proc Natl Acad Sci USA 2004, 101:18147-18152. 10.1073/pnas.0408260101, 539802, 15608061.
7. Ke Q, Ji J, Cheng C, Zhang Y, Lu M, Wang Y, Zhang L, Li P, Cui X, Chen L, et al. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma. Exp Mol Pathol 2009, 87:167-172. 10.1016/j.yexmp.2009.07.011, 19686732.
8. Golipour A, Myers D, Seagroves T, Murphy D, Evan GI, Donoghue DJ, Moorehead RA, Porter LA. The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis. Cancer Res 2008, 68:3591-3600. 10.1158/0008-5472.CAN-07-6453, 18483240.
9. Arason A, Gunnarsson H, Johannesdottir G, Jonasson K, Bendahl PO, Gillanders EM, Agnarsson BA, Jonsson G, Pylkas K, Mustonen A, et al. Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families. Breast Cancer Res 2010, 12:R50. 10.1186/bcr2608, 2949638, 20637093.
10. Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, Chenevix-Trench G, Szabo C, Southey M, Renard H, et al. A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer 2006, 45:646-655. 2714969, 16575876.
11. Al Sorkhy M, Craig R, Market B, Ard R, Porter LA. The cyclin-dependent kinase activator, Spy1A, is targeted for degradation by the ubiquitin ligase NEDD4. J Biol Chem 2009, 284:2617-2627.
12. Dinarina A, Santamaria PG, Nebreda AR. Cell cycle regulation of the mammalian CDK activator RINGO/Speedy A. FEBS Lett 2009, 583:2772-2778. 10.1016/j.febslet.2009.07.028, 19622356.
13. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL. Lee JJ, Tilghman SM, Gumbiner BM, Costantini F: The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 1997, 90:181-192. 10.1016/S0092-8674(00)80324-4, 9230313.
14. Gastwirt RF, Slavin DA, McAndrew CW, Donoghue DJ. Spy1 expression prevents normal cellular responses to DNA damage: Inhibition of apoptosis and checkpoint activation. J Biol Chem 2006,
15. Cheng A, Xiong W, Ferrell JE. Solomon MJ: Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. Cell Cycle 2005, 4:155-165. 10.4161/cc.4.1.1347, 15611625.
16. Kallakury BV, Sheehan CE, Ambros RA, Fisher HA, Kaufman RP. Ross JS: The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma. Cancer 1997, 80:753-763. 10.1002/(SICI)1097-0142(19970815)80:4<753::AID-CNCR15>3.0.CO;2-S, 9264360.
17. Ross JS, Sheehan CE, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman RP. Fisher HA, Rifkin MD, Muraca PJ: Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma. Cancer 1997, 79:2162-2170. 10.1002/(SICI)1097-0142(19970601)79:11<2162::AID-CNCR14>3.0.CO;2-U, 9179063.
18. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, Mao L. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 2000, 60:4000-4004.
19. Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ, Dutta A. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res 1996, 56:4159-4163.
20. Ozen M, Ittmann M. Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer. Clin Cancer Res 2005, 11:4701-4706. 10.1158/1078-0432.CCR-04-2551, 16000564.
21. Cheng A, Gerry S, Kaldis P, Solomon MJ. Biochemical characterization of Cdk2-Speedy/Ringo A2. BMC Biochem 2005, 6:19. 10.1186/1471-2091-6-19, 1262692, 16191191.
22. Liu P, Kao TP, Huang H. CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor. Oncogene 2008, 27:4733-4744. 10.1038/onc.2008.104, 18408765.
23. Yuan Z, Becker EB, Merlo P, Yamada T, DiBacco S, Konishi Y, Schaefer EM, Bonni A. Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons. Science 2008, 319:1665-1668. 10.1126/science.1152337, 18356527.